Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - R
Regulon Inc. Biotechnology company committed to the development of anti-cancer pharmaceuticals. Their objective in developing a broad range of low-toxicity drugs to be used in cancer therapy is based on liposomal encapsulation technology. |
|
Reneuron ReNeuron is a pioneer in stem cell research and development focused on cell therapy treatments designed to reverse the effects of major diseases such as stroke, diabetes and diseases of the retina. |
|
REPLICor Inc. Biopharmaceutical company developing entry inhibitors for the treatment of hepatitis C (HCV) and prevention of HCV re-infection following liver transplantation. The company also targets the hepatitis B and influenza markets. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- FDA approves $4.25 million gene therapy for MLD - PharmaNewsIntel
Fri, 29 Mar 2024 13:30:0 GMT - FDA Approves First Gene Therapy to Treat Children with Metachromatic Leukodystrophy - JD Supra
Fri, 29 Mar 2024 02:46:5 GMT - RGX-314 Gene Therapy for nAMD Well-Tolerated in Phase 1/2a Study - MD Magazine
Thu, 28 Mar 2024 23:12:1 GMT - Nanoscope targets FDA approval following positive gene therapy trial results - Longevity.Technology
Thu, 28 Mar 2024 19:17:3 GMT - Cell And Gene Therapy Manufacturing Services Market Set To Grow At A Rate Of More Than 16% Driven By Rising ... - GlobeNewswire
Thu, 28 Mar 2024 16:31:4 GMT - Cell And Gene Therapy CDMO Market Size to Reach USD 69.11 Bn by 2033 - BioSpace
Thu, 28 Mar 2024 16:06:0 GMT - Trial will test gene therapy for limb-girdle muscular dystrophy type - Muscular Dystrophy News
Thu, 28 Mar 2024 15:27:2 GMT - REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III - Genetic Engineering & Biotechnology News
Thu, 28 Mar 2024 12:05:1 GMT - Gene therapy offers hope for giant axonal neuropathy patients - UT Southwestern
Wed, 27 Mar 2024 16:52:2 GMT - Gene Therapy, DNA's Past, RNA's Future: Early History - Forbes
Wed, 27 Mar 2024 16:20:5 GMT - Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint - BioSpace
Wed, 27 Mar 2024 16:18:4 GMT - Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe - Clinical Trials Arena
Wed, 27 Mar 2024 12:26:4 GMT - Gene therapy maker bluebird to revise financials after accounting errors - Reuters
Tue, 26 Mar 2024 15:55:0 GMT - Why Alzheimer's Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence - Medpage Today
Tue, 26 Mar 2024 15:17:1 GMT - Maryland non-profit sets up gene therapy production in Brazil - FiercePharma
Tue, 26 Mar 2024 13:44:2 GMT